4.4 Article

A Gateway® -compatible bacterial adenylate cyclase-based two-hybrid system

期刊

ENVIRONMENTAL MICROBIOLOGY REPORTS
卷 6, 期 3, 页码 259-267

出版社

WILEY-BLACKWELL
DOI: 10.1111/1758-2229.12123

关键词

-

资金

  1. Pasteur Foundation
  2. Universite Paris Diderot

向作者/读者索取更多资源

The bacterial adenylate cyclase two-hybrid (BACTH) system has been widely used to characterize protein-protein interactions in the prokaryotic world. This system relies on the interaction-mediated reconstitution of adenylate cyclase activity in Escherichia coli by bringing together two complementary fragments of the catalytic domain of the adenylate cyclase toxin of Bordetella pertussis. A limiting factor in performing large-scale two-hybrid interaction screens with full-length open reading frames (ORFs) is the need to clone each ORF individually into the plasmids used to express the hybrid proteins. The Gateway((R)) (GW) cloning system (Life Technologies, Grand Island, NY, USA) partially circumvents this limitation, and we describe here modifications to the BACTH system for compatibility with this recombineering technology. We validated and tested the functionality of the BACTH Gateway (BACTH(GW)) system using several models of protein-protein interactions, focusing particularly on those involved in bacterial cell division. We further modified the BACTH plasmids to incorporate a transmembrane (TM) segment downstream of the cyclase fragments to permit analysis of extracytoplasmic protein interactions. This approach was also useful to identify putative TM segments and to experimentally validate bioinformatically identified TM domains. The BACTH(GW) system will prove a useful addition to the study of protein-protein interactions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Food Science & Technology

The Adenylate Cyclase (CyaA) Toxin from Bordetella pertussis Has No Detectable Phospholipase A (PLA) Activity In Vitro

Alexis Voegele, Mirko Sadi, Dorothee Raoux-Barbot, Thibaut Douche, Mariette Matondo, Daniel Ladant, Alexandre Chenal

TOXINS (2019)

Editorial Material Immunology

Editorial: Pathogens and disease special issue ETOX18

Daniel Ladant, Carmen Buchrieser, Michel R. Popoff

PATHOGENS AND DISEASE (2019)

Article Multidisciplinary Sciences

Functional and structural consequences of epithelial cell invasion by Bordetella pertussis adenylate cyclase toxin

Christelle Angely, Daniel Ladant, Emmanuelle Planus, Bruno Louis, Marcel Filoche, Alexandre Chenal, Daniel Isabey

PLOS ONE (2020)

Article Gastroenterology & Hepatology

Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test

Christian Borup, Signe Wildt, Juri Rumessen, Jesper Graff, Pierre Nordine Bouchelouche, Trine Borup Andersen, Lars Vinter-Jensen, Anna Zaremba, Soren Peter German Jorgensen, Tine Gregersen, Camilla Nojgaard, Hans Bording Timm, Dominique Rainteau, Emilie Gauliard, Lars Kristian Munck

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Article Nutrition & Dietetics

Distinct Postprandial Bile Acids Responses to a High-Calorie Diet in Men Volunteers Underscore Metabolically Healthy and Unhealthy Phenotypes

Antonin Lamaziere, Dominique Rainteau, K. C. Pukar, Lydie Humbert, Emilie Gauliard, Farid Ichou, Maharajah Ponnaiah, Nadine Bouby, Joe-Elie Salem, Jean-Maurice Mallet, Maryse Guerin, Philippe Lesnik

NUTRIENTS (2020)

Review Food Science & Technology

Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Vaccine Development and Other Biotechnological Purposes

Daniel Ladant

Summary: The adenylate cyclase toxin CyaA is a key virulent factor produced by Bordetella pertussis, targeting innate immunity to facilitate bacterial colonization of the respiratory tract. With remarkable characteristics, CyaA has been utilized for various applications in vaccinology and biotechnology. Its engineering as a vaccine vehicle for antigen delivery and as a genetic assay for monitoring protein-protein interactions in bacteria are briefly summarized in this chapter.

TOXINS (2021)

Article Chemistry, Multidisciplinary

A High-Affinity Calmodulin-Binding Site in the CyaA Toxin Translocation Domain is Essential for Invasion of Eukaryotic Cells

Alexis Voegele, Mirko Sadi, Darragh Patrick O'Brien, Pauline Gehan, Dorothee Raoux-Barbot, Maryline Davi, Sylviane Hoos, Sebastien Brule, Bertrand Raynal, Patrick Weber, Ariel Mechaly, Ahmed Haouz, Nicolas Rodriguez, Patrice Vachette, Dominique Durand, Sebastien Brier, Daniel Ladant, Alexandre Chenal

Summary: The P454 segment of the CyaA toxin is capable of translocating across membranes and interacting with calmodulin, with key residues involved in membrane destabilization and calmodulin binding. Inhibitors of calmodulin can efficiently block CyaA internalization. This suggests a potential mechanism for the vectorial translocation of the toxin into host cells.

ADVANCED SCIENCE (2021)

Editorial Material Food Science & Technology

Report from the 27th (Virtual) Meeting on Toxinology, Toxins: Mr Hyde or Dr Jekyll?, Organized by the French Society of Toxinology, 9-10 December 2021

Daniel Ladant, Pascale Marchot, Sylvie Diochot, Gilles Prevost, Michel R. Popoff, Evelyne Benoit

Summary: This report presents the 27th annual meeting of the French Society of Toxinology, which focused on the dual nature of toxins and showcased the latest research findings on plant, fungal, algal, animal, and bacterial toxins.

TOXINS (2022)

Article Microbiology

Prevalence of ExoY Activity in Pseudomonas aeruginosa Reference Panel Strains and Impact on Cytotoxicity in Epithelial Cells

Hazel Silistre, Dorothee Raoux-Barbot, Federica Mancinelli, Flora Sangouard, Alice Dupin, Alexander Belyy, Vincent Deruelle, Louis Renault, Daniel Ladant, Lhousseine Touqui, Undine Mechold

Summary: ExoY is an effector injected by Pseudomonas aeruginosa into host cells, with prevalence among strains and the potential to partly alleviate the cytotoxic effects of other virulence factors under certain conditions.

FRONTIERS IN MICROBIOLOGY (2021)

Article Biology

Dynamics and structural changes of calmodulin upon interaction with the antagonist calmidazolium

Corentin Leger, Irene Pitard, Mirko Sadi, Nicolas Carvalho, Sebastien Brier, Ariel Mechaly, Dorothee Raoux-Barbot, Maryline Davi, Sylviane Hoos, Patrick Weber, Patrice Vachette, Dominique Durand, Ahmed Haouz, J. Inaki Guijarro, Daniel Ladant, Alexandre Chenal

Summary: We conducted a molecular characterization of CaM:CDZ complexes using SEC-SAXS, X-ray crystallography, HDX-MS, and NMR methods. The binding of CDZ causes conformational reorientation of CaM and stabilizes its structural elements, leading to reduced protein dynamics. Residues involved in the stabilization of the CaM:CDZ complex were identified. These findings provide insights into CDZ-induced dynamics and structural changes of CaM, which can be used for the design of more selective CaM antagonists.

BMC BIOLOGY (2022)

Article Food Science & Technology

A Robust and Sensitive Spectrophotometric Assay for the Enzymatic Activity of Bacterial Adenylate Cyclase Toxins

Marilyne Davi, Mirko Sadi, Irene Pitard, Alexandre Chenal, Daniel Ladant

Summary: Various bacterial pathogens are producing toxins that target the cyclic Nucleotide Monophosphate (cNMPs) signaling pathways in order to facilitate host colonization. Here we describe a simple and robust in vitro assay for AC activity based on the spectrophotometric detection of cyclic AMP (cAMP) after chromatographic separation on aluminum oxide.

TOXINS (2022)

Article Immunology

SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity

Zuzana Antosova, Nada Podzimkova, Jakub Tomala, Katerina Augustynkova, Katerina Sajnerova, Eva Nedvedova, Milada Sirova, Guy de Martynoff, David Bechard, Ulrich Moebius, Marek Kovar, Radek Spisek, Irena Adkins

Summary: SOT101, a potential clinical candidate for cancer treatment, activates NK cells and CD8(+) T cells and enhances their cytotoxicity against tumor cells. When used in combination with approved monoclonal antibodies, it increases the killing of tumor cells. In an animal model, the combination of SOT101 and Daratumumab showed the strongest anti-tumor effect, supporting further investigation of this combination in clinical studies.

FRONTIERS IN IMMUNOLOGY (2022)

Editorial Material Food Science & Technology

Editorial of the Special Issue Toxins: Mr Hyde or Dr Jekyll?

Daniel Ladant, Gilles Prevost, Michel R. Popoff, Evelyne Benoit

TOXINS (2023)

Meeting Abstract Oncology

SOT201 is a novel targeted IL-15Rbg agonist to alleviate PD-1-mediated immune cell suppression and potentiate anti-tumor efficacy

Irena Adkins, Zuzana Antosova, Klara Danova, Kamila Hladikova, Katerina Augustynkova, Katerina Sajnerova, Nada Podzimkova, Pavel Marasek, Guy de Martynoff, David Bechard, Ulrich Moebius, Radek Spisek

CANCER RESEARCH (2022)

Meeting Abstract Oncology

SO-C101 INDUCES NK CELL CYTOTOXICITY AND POTENTIATES ANTIBODY-DEPENDENT CELL CYTOTOXICITY AND ANTI-TUMOR ACTIVITY

Zuzana Antosova, Nada Podzimkova, Marketa Jiratova, Eva Nedvedova, Guy De Martynoff, David Bechard, Ulrich Moebius, Radek Spisek, Irena Adkins

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

暂无数据